Source: Health Products Regulatory Authority (ZA) Revision Year: 2023 Publisher: Ranbaxy Pharmaceuticals (Pty) Ltd, 14 Lautre Road, Stormill, Ext. 1, Roodepoort, 1724, South Africa
PYROCAPS Capsule.
| Pharmaceutical Form |
|---|
|
Capsules. PROCAPS. Capsules with an opaque white body and opaque maroon cap. |
Each PYROCAPS capsule contains 20 mg Piroxicam.
Contains sugar: lactose 214 mg per capsule.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Piroxicam |
Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation. |
| List of Excipients |
|---|
|
The capsule also contains: Lactose 200 mesh (fast flow) |
Bottles of 30 capsules.
Patient ready packs of different pack sizes.
Ranbaxy Pharmaceuticals (Pty) Ltd, 14 Lautre Road, Stormill, Ext. 1, Roodepoort, 1724, South Africa
27/3.1/0187
February 1993
| Drug | Countries | |
|---|---|---|
| PYROCAPS | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
